In summary, our study reveals that Egr1 is a sex-dependent IEG, capable of initiating and maintaining neuronal chromatin accessibility sex-dependently, with consequences for targeted gene expression changes, structural plasticity, and anxiety- and depression-related behaviour. Here, EGR1 is linked to depressive symptom measurement.